A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 16th-20th May.
TURKU, Finland, May 18, 2022 /PRNewswire/ DelSiTech Ltd, the leading silica drug delivery technology company, based in Finland and Anticancer Bioscience Ltd., an innovative China-base and
Chengdu, China (PRUnderground) March 1st, 2021
Anticancer Biosciences is applying its synthetic lethality expertise for better cancer therapies. The identification of novel antimitotic agents that do not lead to severe side effects is much significant in the present day oncology drug development. At the J. Michael Bishop Institute of Cancer Research (MBICR), China’s world-leading cancer research Centre, there are many advanced research initiatives in this context.
A recently published study from our Natural Product Drug Discovery Group (NPDD) highlights a novel screening method in uncovering the next generation of antimitotic natural compounds. The study, entitled ‘Purification, identification, and characterization of two benzophenanthridine alkaloids from Corydalis longicalcarata rhizomes with anti-mitotic and polyploidy-inducing activities’, was published in “Phytochemistry Letters”, an Official Journal of the Phytochemical Society of Europe, on 7th January 2021. The r